Tom P Freeman (Tom Freeman)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 37

Top Topics

Aortic Dissection

Top Venues

Addiction (Abingdon, England)

Translational psychiatry

Journal of psychopharmacology (Oxford, England)

Psychological medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tom P Freeman, Edward Beeching, Sam Craft, Marta Di Forti, Giampietro Frison, Christian Lindholst, Pieter E Oomen, David Potter, Sander Rigter, Kristine Rømer Thomsen, Luca Zamengo, Andrew Cunningham, Teodora Groshkova, Roumen Sedefov
Applying machine learning to international drug monitoring: classifying cannabis resin collected in Europe using cannabinoid concentrations. European archives of psychiatry and clinical neuroscience (2024)
Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freeman
Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry 13 (1) (2023)
Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freeman
Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry 13 (1) (2023)
Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freeman
Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry 13 (1) (2023)
Tom P Freeman, Valentina Lorenzetti
Using the standard THC unit to regulate THC content in legal cannabis markets. Addiction (Abingdon, England) (2023)
Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freeman
Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry 13 (1) (2023)
Tom P Freeman, Wayne Hall
Benefits and risks of cannabinoids. BMJ (Clinical research ed.) 382 (2023)
Tom P Freeman, Valentina Lorenzetti
Using the standard THC unit to regulate THC content in legal cannabis markets. Addiction (Abingdon, England) (2023)
Dominic Oliver, Amir Englund, Edward Chesney, Lucy A Chester, Jack Wilson, Simina Sovi, Stina Wigroth, John Hodsoll, Sir John Strang, Robin M Murray, Tom P Freeman, Paolo Fusar-Poli, Philip K McGuire
Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study. Addiction (Abingdon, England) (2023)
Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freeman
Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry 13 (1) (2023)
Will Lawn, Katie Trinci, Claire Mokrysz, Anna Borissova, Shelan Ofori, Kat Petrilli, Michael Bloomfield, Zarah R Haniff, Daniel Hall, Natalia Fernandez-Vinson, Simiao Wang, Amir Englund, Edward Chesney, Matthew B Wall, Tom P Freeman, H Valerie Curran
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment. Addiction (Abingdon, England) (2023)
Daniel Ying-Heng Hua, Chandni Hindocha, Gianluca Baio, Rachel Lees, Natacha Shaban, Celia J Morgan, Ali Mofeez, H Valerie Curran, Tom P Freeman
Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder. Translational psychiatry 13 (1) (2023)
Will Lawn, Katie Trinci, Claire Mokrysz, Anna Borissova, Shelan Ofori, Kat Petrilli, Michael Bloomfield, Zarah R Haniff, Daniel Hall, Natalia Fernandez-Vinson, Simiao Wang, Amir Englund, Edward Chesney, Matthew B Wall, Tom P Freeman, H Valerie Curran
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment. Addiction (Abingdon, England) (2023)
Will Lawn, Katie Trinci, Claire Mokrysz, Anna Borissova, Shelan Ofori, Kat Petrilli, Michael Bloomfield, Zarah R Haniff, Daniel Hall, Natalia Fernandez-Vinson, Simiao Wang, Amir Englund, Edward Chesney, Matthew B Wall, Tom P Freeman, H Valerie Curran
THE ACUTE EFFECTS OF CANNABIS WITH AND WITHOUT CANNABIDIOL IN ADULTS AND ADOLESCENTS: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER EXPERIMENT. Addiction (Abingdon, England) (2023)
Will Lawn, Katie Trinci, Claire Mokrysz, Anna Borissova, Shelan Ofori, Kat Petrilli, Michael Bloomfield, Zarah R Haniff, Daniel Hall, Natalia Fernandez-Vinson, Simiao Wang, Amir Englund, Edward Chesney, Matthew B Wall, Tom P Freeman, H Valerie Curran
The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment. Addiction (Abingdon, England) (2023)
Valentina Lorenzetti, Chandni Hindocha, Kat Petrilli, Paul N Griffiths, Jamie Brown, Álvaro Castillo-Carniglia, Jonathan P Caulkins, Amir Englund, Mahmoud A El Sohly, Suzanne H Gage, Teodora Groshkova, Antoni Gual, David Hammond, Will Lawn, Hugo López-Pelayo, Jakob Manthey, Claire Mokrysz, Rosalie Liccardo Pacula, Margriet W van Laar, Ryan Vandrey, Elle Wadsworth, Adam Winstock, Wayne Denis Hall, H Valerie Curran, Tom P Freeman
The iCannTookit: a consensus-based, flexible framework for measuring contemporary cannabis use. Addiction (Abingdon, England) 117 (9) (2022)
Tom P Freeman, Jenny Scott, Gemma M J Taylor
Evidence from naturalistic studies can be strengthened by triangulation. Addiction (Abingdon, England) 117 (8) (2022)
Jack Wilson, Katherine L Mills, Tom P Freeman, Matthew Sunderland, Rachel Visontay, Christina Marel
Response to Bahji et al.: Limitations of the available evidence that restrict our interpretation of the transition from cannabis to opioid use. Addiction (Abingdon, England) 117 (10) (2022)
Kristin Feltmann, Tobias H Elgán, Anna K Strandberg, Pia Kvillemo, Nitya Jayaram-Lindström, Meryem Grabski, Jon Waldron, Tom P Freeman, Helen Valerie Curran, Johanna Gripenberg
Illicit Drug Use and Associated Problems in the Nightlife Scene: A Potential Setting for Prevention. International journal of environmental research and public health 18 (9) (2021)
Jack Wilson, Katherine L Mills, Tom P Freeman, Matthew Sunderland, Rachel Visontay, Christina Marel
Weeding out the truth: a systematic review and meta-analysis on the transition from cannabis use to opioid use and opioid use disorders, abuse or dependence. Addiction (Abingdon, England) (2021)
Valentina Lorenzetti, Chandni Hindocha, Kat Petrilli, Paul N Griffiths, Jamie Brown, Álvaro Castillo-Carniglia, Jonathan P Caulkins, Amir Englund, Mahmoud A Sohly, Suzanne H Gage, Teodora Groshkova, Antoni Gual, David Hammond, Will Lawn, Hugo López Pelayo, Jakob Manthey, Claire Mokrysz, Rosalie Liccardo Pacula, Margriet W van Laar, Ryan Vandrey, Elle Wadsworth, Adam Winstock, Wayne Denis Hall, Helen Valerie Curran, Tom P Freeman
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use. Addiction (Abingdon, England) (2021)
Tom P Freeman, Michael T Nurmohamed
Minimum THC unit pricing: an opportunity for harm reduction. Addiction (Abingdon, England) 116 (2) (2020)
Tom P Freeman, Sam Craft, Jack Wilson, Stephan Stylianou, Mahmoud ElSohly, Marta Di Forti, Michael T Nurmohamed
Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Addiction (Abingdon, England) 116 (5) (2020)
Tom P Freeman, Valentina Lorenzetti
Moving forwards with the standard THC unit. Addiction (Abingdon, England) 115 (7) (2020)
Tom P Freeman, Valentina Lorenzetti
'Standard THC units': a proposal to standardize dose across all cannabis products and methods of administration. Addiction (Abingdon, England) 115 (7) (2019)
Tom P Freeman, Teodora Groshkova, Andrew Cunningham, Roumen Sedefov, Paul Griffiths, Michael T Nurmohamed
Increasing potency and price of cannabis in Europe, 2006-16. Addiction (Abingdon, England) 114 (6) (2019)
Kristine Rømer Thomsen, Christian Lindholst, Birgitte Thylstrup, Sinikka Kvamme, Lotte Ask Reitzel, Martin Worm-Leonhard, Amir Englund, Tom P Freeman, Morten Hesse
Changes in the composition of cannabis from 2000-2017 in Denmark: Analysis of confiscated samples of cannabis resin. Experimental and clinical psychopharmacology 27 (4) (2019)
Matthew B Wall, Rebecca Pope, Tom P Freeman, Oliwia S Kowalczyk, Lysia Demetriou, Claire Mokrysz, Chandni Hindocha, Will Lawn, Michael Ap Bloomfield, Abigail M Freeman, Amanda Feilding, David Nutt, H Valerie Curran
Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity. Journal of psychopharmacology (Oxford, England) 33 (7) (2019)
Claire Mokrysz, Tom P Freeman
Commentary on Meier et al. (2018): Smoke and mirrors-are adolescent cannabis users vulnerable to cognitive impairment? Addiction (Abingdon, England) 113 (2) (2019)
Tom P Freeman, Jack Wilson, Clare Mackie
Commentary on Salloum et al. (2018): Rethinking adolescent cannabis use and risk perception. Addiction (Abingdon, England) 113 (6) (2019)
Tom P Freeman, Mitul A Mehta, Joanna C Neill, David J Nutt, Elizabeth M Tunbridge, Allan H Young
Restrictions on drugs with medical value: Moving beyond stalemate. Journal of psychopharmacology (Oxford, England) 32 (10) (2018)
Celia J A Morgan, Tom P Freeman, Chandni Hindocha, Grainne Schafer, Chelsea Gardner, H Valerie Curran
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Translational psychiatry 8 (1) (2018)
Chandni Hindocha, Tom P Freeman, Meryem Grabski, Jack B Stroud, Holly Crudgington, Alan C Davies, Ravi K Das, William Lawn, Celia J A Morgan, H Valerie Curran
Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. Addiction (Abingdon, England) (2018)
H Valerie Curran, Chandni Hindocha, Celia J A Morgan, Natacha Shaban, Ravi K Das, Tom P Freeman
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects? Psychological medicine 49 (9) (2018)
Meryem Grabski, H Valerie Curran, David J Nutt, Stephen M Husbands, Tom P Freeman, Meg Fluharty, Marcus R Munafò
Behavioural tasks sensitive to acute abstinence and predictive of smoking cessation success: a systematic review and meta-analysis. Addiction (Abingdon, England) 111 (12) (2016)
Michael T Lynskey, Chandni Hindocha, Tom P Freeman
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use. Addiction (Abingdon, England) 111 (12) (2016)
Chandni Hindocha, Tom P Freeman, Adam R Winstock, Michael T Lynskey
Vaping cannabis (marijuana) has the potential to reduce tobacco smoking in cannabis users. Addiction (Abingdon, England) 111 (2) (2015)